Skip to main content

Analogies between the periphery of cancer and the leading edge of pulmonary fibrosis


The periphery of malignant tumors and the leading edge of fibrotic tissue have analogous metabolic pathways. Both use glycolysis as the primary source of energy to produce biomass with consequential acidification of the microenvironment. A low PH has been shown to increase the ability of cancer cells to invade the surrounding tissue in both in vitro and in vivo studies. The pH-dependent activation of TGF-B leading to myofibroblast activation is an important step in the initiation and progression of fibrosis. Markers of accelerated cell proliferation have also been reported in the periphery of malignant tumors and the leading edge of fibrosis. Understanding the shared molecular and metabolic characteristics of these conditions may explain the increased prevalence of cancer among patients with fibrosis.

Anaerobic glycolysis utilizes one glucose molecule and 2 ATP to create 4 ATP, 2 pyruvates, and 2 NADH [1] (Fig. 1). Pyruvate is converted to lactate in the cytoplasm and transported to the extracellular matrix in a hypoxic environment. In the presence of oxygen, pyruvate enters the mitochondria and joins with coenzyme A to form acetyl-CoA in the Krebs cycle and ultimately yields 2 ATP, 2 FADH2, and 6 NADH. Electron transport phosphorylation in the mitochondria converts 2 FADH2 and 6 NADH to 32 ATP [1]. Tumors preferentially use glycolysis for energy production despite the relatively low levels of ATP production in what is called the Warburg effect. The hypothesized reasons for a switch to glycolysis include abnormal tumor mitochondria preventing oxidative phosphorylation, relative hypoxia, the need for more rapid ATP production, and the creation of biomass which seems most likely [2]. The excess carbon produced by glycolysis in the form of lactate allows faster incorporation of carbon into biomass, which in turn facilitates rapid cell division beneficial for a growing tumor [3].

Fig. 1
figure 1

Diagrammatic representation of the production of 4 ATP, 2 pyruvates, and 2 NADH from one glucose molecule and 2 ATP through anaerobic glycolysis

Tumors are heterogeneous and their heterogeneity can be validated with radiologic imaging (Fig. 2). Gillies described how the core of a tumor is different from its edge and that the interface between the tumor and stroma provides prognostic value [4]. Lloyd et al. found that Ki67, a marker of cell proliferation, is much higher at the edge of a tumor which is not surprising given the tumor’s need to increase biomass at its leading edge [5]. The majority of cells in the human body use oxidative phosphorylation (OXPHOS) for ATP production as a source of energy, however, when cells are actively proliferating in regenerating tissues or cancer, they need to increase their biomass with the anabolic building blocks provided by glycolysis [6].

Fig. 2
figure 2

Heterogenous lung tumor showed on CT scan (photograph detail from an axial cut). On the right, a diagram illustrating the difference between the center and the leading edge of the tumor

In further support of increased glycolysis at the tumor periphery, Lloyd found increased Glut1 associated with the utilization of glucose. He identified increased carbonic anhydrase 9, a marker of extracellular acidity. Carbonic anhydrase 9 participates in the mobilization of hydrogen ions in the cytoplasm to the extracellular matrix [4, 5]. The hypoxia-inducible factor 1 (HIF1) is of paramount importance in regulating the body’s response to hypoxia at the cellular level. HIF is composed of 2 proteins; HIF-1B and HIF-1 alpha or HIF-2 alpha. HIF-1 alpha responds to low oxygen caused by increased biomass or decreased oxygen availability due to distance from vessels and facilitates the process of angiogenesis. HIF-1 alpha affects tumor metabolism including the utilization of glucose and the production of lactate [7].

We extrapolated these tumor metabolism principles to idiopathic pulmonary fibrosis (IPF) where the radiographic pattern is usual interstitial pneumonitis characterized as subpleural fibrosis with honeycombing (Fig. 3). Repeated micro-injury to the alveolar epithelial cells has been recognized as the initiating event in the altered repair process of IPF [8]. As pulmonary fibrosis progresses the leading edge of the fibrosis moves from peripheral to central in the lung. The laying down of collagen requires biomass production which would require a shift to glycolysis. Glycolysis increases lactate production causing a lowering of the PH in the periphery of the fibrosis where there is progression. Analogous to the periphery of a tumor, we would expect elevated HIF-1alpha due to the relative hypoxia and elevated Glut1 due to glucose utilization and elevated CA9 related to acidosis secondary to extra lactate. Zhao provided proof of these concepts by studying fibrotic lungs where he found no change in the early-stage glycolysis metabolites, glucose and fructose 6-phosphate, but significantly decreased levels of later-stage glycolysis metabolites compared with normal lungs. They also found increased lactic acid levels [9].

Fig. 3
figure 3

Idiopathic pulmonary fibrosis observed on CT scan (photograph detail from an axial cut). On the right, a diagram illustrating the presence of the leading edge of the fibrotic tissue replacing healthy lung parenchyma from the periphery to the center

Cancer is increased in patients with pulmonary fibrosis (Fig. 4). Kottmann et al. identified lactic acid as an important mediator of myofibroblast differentiation via a pH-dependent activation of TGF-β. It plays a potential role in the initiation and progression of fibrosis [10]. Epstein et al. provided further support that HIF-1 alpha promotes fibrosis [11]. Lactic acidosis can cause a phenotypic switch of macrophages from M1 to M2, which is the form involved in tissue remodeling [12].

Fig. 4
figure 4

Malignant lung tumor in a patient with pulmonary fibrosis observed on CT scan

PET imaging with FDG demonstrates how both cancer cells and pulmonary fibrosis utilize glycolysis as an energy resource (Fig. 5) [13]. 18F-FDG PET/CT has been studied in pulmonary fibrosis. There is increased pulmonary 18F-FDG metabolism corresponding to fibrosis on CT. The authors found that the metabolism was greater in areas of reticulation compared with areas of ground glass [14].

Fig. 5
figure 5

PET imaging with FDG demonstrates how both cancer cells and pulmonary fibrosis utilize glycolysis as an energy resource


The need for increased biomass at the leading edge of tumors and fibrosis cause them both to rely on glycolysis with its resulting acidic microenvironment. This low pH microenvironment with its effect on RAS and TGF-B could explain at least in part the risk for cancer in fibrosis [15]. PET imaging with its ability to identify the highest areas of glucose utilization may provide deeper insight. Further investigation will determine if imaging supports this hypothesis.


  1. Chaudhry R, Varacallo M. Biochemistry, glycolysis. In: StatPearls. Treasure Island: StatPearls Publishing; 2022.

    Google Scholar 

  2. Yu L, Chen X, Sun X, Wang L, Chen S. The glycolytic switch in tumors: how many players are involved? J Cancer. 2017;8(17):3430–40.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Parks SK, Mueller-Klieser W, Pouysségur J. Lactate and acidity in the cancer microenvironment. Annu Rev Cancer Biol. 2020;4:141–58.

    Article  Google Scholar 

  4. Gillies RJ. Cancer heterogeneity and metastasis: life at the edge. Clin Exp Metastasis. 2022;39(1):15–9.

    Article  CAS  PubMed  Google Scholar 

  5. Lloyd MC, et al. Darwinian dynamics of intra-tumoral heterogeneity: not solely random mutations but also variable environmental selection forces. Cancer Res. 2016;76(11):3136–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Weidemann A, Johnson R. Biology of HIF-1α. Cell Death Differ. 2008;15:621–7.

    Article  CAS  PubMed  Google Scholar 

  8. Sgalla G, Iovene B, Calvello M, Ori M, Varone F, Richeldi L. Idiopathic pulmonary fibrosis: pathogenesis and management. Respir Res. 2018;19(1):32.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Zhao YD, Yin L, Archer S, et al. Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study. BMJ Open Respir Res. 2017;4: e000183.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Kottmann RM, Kulkarni AA, Smolnycki KA, et al. Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med. 2012;186(8):740–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Epstein Shochet G, Bardenstein-Wald B, McElroy M, Kukuy A, Surber M, Edelstein E, Pertzov B, Kramer MR, Shitrit D. Hypoxia inducible factor 1A supports a pro-fibrotic phenotype loop in idiopathic pulmonary fibrosis. Int J Mol Sci. 2021;22(7):3331.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Colegio OR, et al. Functional polarization of tumor-associated macrophages by tumor-derived lactic acid. Nature. 2014;513(7519):559–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Vansteenkiste JF, Stroobants SG. The role of positron emission tomography with 18F-fluoro-2-deoxy-d-glucose in respiratory oncology. Eur Respir J. 2001;17(4):802–20.

    Article  CAS  PubMed  Google Scholar 

  14. Groves AM, Win T, Screaton NJ, Berovic M, Endozo R, Booth H, Kayani I, Menezes LJ, Dickson JC, Ell PJ. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT. J Nucl Med. 2009;50(4):538–45.

    Article  PubMed  Google Scholar 

  15. Damaghi M, West J, Robertson-Tessi M, Xu L, Ferrall-Fairbanks MC, Stewart PA, Persi E, Fridley BL, Altrock PM, Gatenby RA, Sims PA, Anderson ARA, Gillies RJ. The harsh microenvironment in early breast cancer selects for a Warburg phenotype. Proc Natl Acad Sci USA. 2021;118(3): e2011342118.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations



MS carried out the study conception. MS and MPM participated in the manuscript draft and preparation. MS provided the supplemental images. MS designed and elaborated illustration 1 (figure 1). MS and MPM participated in the design and elaboration of the supplemental illustrations included in figures 3 and 4.

Corresponding author

Correspondence to Monica Pernia Marin.

Ethics declarations

Competing interests

Mary M. Salvatore—Grant support, lecture, and advisory board Genentech and Boehringer Ingelheim. Image analysis for AbbVie, Bioclinica, LungLife AI. The remaining author have no conflicts to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pernia Marin, M., Salvatore, M. Analogies between the periphery of cancer and the leading edge of pulmonary fibrosis. J Transl Med 21, 274 (2023).

Download citation

  • Published:

  • DOI: